Paul K. Wotton

2014

In 2014, Paul K. Wotton earned a total compensation of $1.4M as Former Chief Executive Officer at Antares Pharma, a 30% decrease compared to previous year.

Compensation breakdown

Option Awards$275,047
Salary$332,468
Stock Awards$798,302
Other$7,001
Total$1,412,818

Wotton received $798.3K in stock awards, accounting for 57% of the total pay in 2014.

Wotton also received $275K in option awards, $332.5K in salary and $7K in other compensation.

Rankings

In 2014, Paul K. Wotton's compensation ranked 6,046th out of 13,032 executives tracked by ExecPay. In other words, Wotton earned more than 53.6% of executives.

ClassificationRankingPercentile
All
6,046
out of 13,032
54th
Division
Manufacturing
2,188
out of 4,966
56th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
267
out of 736
64th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
145
out of 446
68th
Industry
Surgical and Medical Instruments and Apparatus
77
out of 275
72nd
Source: SEC filing on April 15, 2015.

Wotton's colleagues

We found four more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2014.

2014

Eamonn Hobbs

Antares Pharma

Chief Executive Officer

2014

Robert Apple

Antares Pharma

Chief Operating Officer

2014

Jennifer Stacey

Antares Pharma

General Counsel

2014

James Fickenscher

Antares Pharma

Chief Financial Officer

You may also like